Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.

ABSTRACT: Annual influenza epidemics cause substantial morbidity and mortality, and the majority of patients with influenza-like illness present to primary care. Point-of-care influenza tests could support treatment decisions. It is critical to establish analytic performance of these platforms in real-life patient samples before uptake can be considered. We aimed to assess the analytical performance and ease of use of the cobas® Liat® PCR POCT in detecting influenza A/B and RSV in samples collected from patients with influenza-like illness in primary care. Sensitivity and specificity of the cobas® Liat® POCT are calculated in comparison with a commercial laboratory-based PCR test (Fast-Track Respiratory Pathogens 21 Plus kit (Fast-Track Diagnostics)). Samples with discordant results were analysed ad

SUBMITTER: Verbakel JY 

PROVIDER: S-EPMC7343728 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature